ES2523663T3 - Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV - Google Patents

Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV Download PDF

Info

Publication number
ES2523663T3
ES2523663T3 ES06753441.2T ES06753441T ES2523663T3 ES 2523663 T3 ES2523663 T3 ES 2523663T3 ES 06753441 T ES06753441 T ES 06753441T ES 2523663 T3 ES2523663 T3 ES 2523663T3
Authority
ES
Spain
Prior art keywords
matrix
content
active substance
layer
absorbing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06753441.2T
Other languages
English (en)
Spanish (es)
Inventor
Thomas Langguth
Stefan Bracht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Application granted granted Critical
Publication of ES2523663T3 publication Critical patent/ES2523663T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES06753441.2T 2005-05-02 2006-04-28 Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV Active ES2523663T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05009579 2005-05-02
EP05009579A EP1719504A1 (de) 2005-05-02 2005-05-02 Festes transdermales therapeutisches System mit UV-Absorber
PCT/EP2006/003959 WO2006117139A2 (de) 2005-05-02 2006-04-28 Festes transdermales therapeutisches system mit uv-absorber

Publications (1)

Publication Number Publication Date
ES2523663T3 true ES2523663T3 (es) 2014-11-28

Family

ID=34981458

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06753441.2T Active ES2523663T3 (es) 2005-05-02 2006-04-28 Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV

Country Status (26)

Country Link
EP (2) EP1719504A1 (ja)
JP (2) JP5360877B2 (ja)
KR (2) KR101426218B1 (ja)
CN (2) CN108969507A (ja)
AR (1) AR055927A1 (ja)
AU (1) AU2006243442A1 (ja)
BR (1) BRPI0611087A2 (ja)
CA (1) CA2605112C (ja)
CR (1) CR9483A (ja)
CY (1) CY1115757T1 (ja)
DK (1) DK1879560T3 (ja)
DO (1) DOP2006000100A (ja)
EA (1) EA200702344A1 (ja)
ES (1) ES2523663T3 (ja)
GT (1) GT200600183A (ja)
IL (1) IL186945A0 (ja)
MX (1) MX2007013779A (ja)
NO (1) NO20076187L (ja)
PE (1) PE20061414A1 (ja)
PL (1) PL1879560T3 (ja)
PT (1) PT1879560E (ja)
SI (1) SI1879560T1 (ja)
TW (1) TW200719902A (ja)
UY (1) UY29511A1 (ja)
WO (1) WO2006117139A2 (ja)
ZA (1) ZA200710418B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1594483E (pt) 2003-02-21 2006-12-29 Schering Ag Penso transdérmico estável aos uv
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
HUE031326T2 (hu) 2010-09-06 2017-07-28 Bayer Ip Gmbh Alacsony dózisú transzdermális tapaszok magas hatóanyagleadással

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
EP0453396B1 (de) * 1990-03-30 1995-12-13 Ciba SC Holding AG Lackzusammensetzungen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US6924410B2 (en) * 2000-03-17 2005-08-02 Hisamitsu Pharmaceutical Co., Ltd. Ultraviolet-screening patch
EP1452173A1 (de) * 2003-02-25 2004-09-01 Schering AG UV-stabiles transdermales Pflaster
PT1594483E (pt) 2003-02-21 2006-12-29 Schering Ag Penso transdérmico estável aos uv
EP1664128B1 (en) * 2003-09-11 2009-01-21 Ciba Holding Inc. Water based concentrated product forms of light stabilizers made by a heterophase polymerization technique

Also Published As

Publication number Publication date
PE20061414A1 (es) 2007-01-26
MX2007013779A (es) 2008-01-22
PL1879560T3 (pl) 2015-02-27
GT200600183A (es) 2007-01-03
EA200702344A1 (ru) 2008-12-30
EP1719504A1 (de) 2006-11-08
KR101351161B1 (ko) 2014-01-14
NO20076187L (no) 2007-11-30
EP1879560A2 (de) 2008-01-23
UY29511A1 (es) 2006-08-31
TW200719902A (en) 2007-06-01
AR055927A1 (es) 2007-09-12
EP1879560B1 (de) 2014-08-27
CN101171001A (zh) 2008-04-30
SI1879560T1 (sl) 2015-01-30
CA2605112C (en) 2013-11-05
CA2605112A1 (en) 2006-11-09
BRPI0611087A2 (pt) 2010-08-03
WO2006117139A3 (de) 2007-04-19
JP5360877B2 (ja) 2013-12-04
DOP2006000100A (es) 2007-01-31
CR9483A (es) 2008-01-21
AU2006243442A1 (en) 2006-11-09
CY1115757T1 (el) 2017-01-25
ZA200710418B (en) 2009-08-26
KR101426218B1 (ko) 2014-08-05
JP2013177451A (ja) 2013-09-09
JP2008540352A (ja) 2008-11-20
IL186945A0 (en) 2008-02-09
CN108969507A (zh) 2018-12-11
KR20080003854A (ko) 2008-01-08
DK1879560T3 (en) 2014-11-24
PT1879560E (pt) 2014-11-19
WO2006117139A2 (de) 2006-11-09
KR20130099203A (ko) 2013-09-05

Similar Documents

Publication Publication Date Title
AR043248A1 (es) Sistema terapeutico transdermico estable a los rayos uv
ES2543977T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
AR097045A2 (es) Sistema terapéutico transdérmico
ES2524696T3 (es) Vendaje del tejido de la mucosa y método de uso
AR062772A1 (es) Aposito de pelicula delgada
AR054300A1 (es) Aparato y sistema de microproyeccion con escaso potencial infeccioso
ATE369825T1 (de) Wundauflage
ES2529662T3 (es) Parche adhesivo médico
DE50103257D1 (de) Absorptionsmittel und kanalbildner enthaltende wirkstoffundurchlässige deckschicht oder abziehbare schutzschicht eines transdermalen therapeutischen systems
ES2523663T3 (es) Sistema terapéutico transdérmico sólido con un agente absorbente de los rayos UV
AR009516A1 (es) Un dispositivo de parche de matriz adhesiva sensible a la presion, un metodo para preparar dicho dispositivo y un metodo para emplear dichodispositivo en el suministro transdermico de una droga.
CO6341593A2 (es) Estructura plastica absorbente de oxigeno
PA8815901A1 (es) Sistema de administracion de drogas con efecto estabilizante
ES2513691T3 (es) Preparación transdérmica
AR070031A1 (es) Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas
ECSP11010762A (es) Composición tópica para el tratamiento de queratosis actínica
AR054012A1 (es) Sistema terapeutico transdermico para la adminstracion de analgesicos
AR025390A1 (es) Sistema terapeutico que contiene un principio activo para su aplicacion sobre la piel, con un minimo de dos capas que contengan polimeros
AR058843A1 (es) Panel de barrera
BR112019007325A2 (pt) sistema terapêutico tópico de duas camadas
CL2009001085A1 (es) Tampón que comprende primer aposito, segundo apósito o capa absorbente, y un escudo de fugasque puede estar compuesto de : una pélicula polimérica impermeable o repelente a fluidos, o un material absorbente o hidrofílico, o tres o mas capas; y método para fabricar un tampón.
BR0313092A (pt) Sistema de liberação transdérmica aperfeiçoado
PT1284718E (pt) Sistema terapeutico transdermal oclusivo com uma camada de reforco nao oclusiva
AR039137A1 (es) Unidad coherente de sistemas terapeuticos transdermicos separables
YU3390A (sh) Postupak za izradu površinskog terapijskog sistema sa sadržajem antineoplastične aktivne materije, naročito 5-fluor-uracila